(Q39971422)
Statements
1 reference
Rosiglitazone counteracts palmitate-induced beta-cell dysfunction by suppression of MAP kinase, inducible nitric oxide synthase and caspase 3 activities (English)
1 reference
S Meidute Abaraviciene
1 reference
I Lundquist
1 reference
1 July 2008
1 reference
1 reference
2256-2265
1 reference
Identifiers
1 reference